In-depth coverage of investigational and approved drugs

Thomson Pharma generates reports that contain premium information pulled from a wide range of sources, including detailed monographs of more than 29,000 drugs.

With Thomson Pharma, you can gather essential scientific, intellectual property, commercial, and financial information about drugs at all stages of the development pipeline, from discovery and clinical trials through to launch and sales.

With Thomson Pharma you can:

Stay up-to-date

• Obtain updates about new drugs and compounds, filtered by specific therapeutic area and chemical structure, or limited by action, therapy area, company, chemical structure, substructure, or homology
• Receive alerts about changes in phase for drugs, filtered by high-level therapy area
• Scan daily-updated news headlines about investigational and approved drugs and read the full story detailed in the original press release
• Hear about the latest meetings and conferences in your field with links to specially written reports
• Monitor the latest drug discoveries, however they are disclosed, and access extensive overviews of significant drugs in key therapy areas

Monitor drug development

• View continuously-updated, detailed information on a drug’s development
• See how drugs are progressing through the pipeline
• Search and view a list of drugs according to the highest development status, or the same therapeutic application and actions
• Discover where a drug stands from an intellectual property perspective by viewing value-added patent data and linking to original patent documents

View launched drug information

• Look at sales and market information for blockbuster and other approved drugs and analyze the predicted financial impact of new drugs
• View comprehensive data about marketed drug prescription usage in the USA

Examine chemical structures

• Examine the chemical structure of a drug and see all associated compound names
• Review in-depth ADMET data

Export your results

• Export your results to Microsoft® Word, Excel or the BizInt pipeline database analysis tool

Where next? Intellectual property